Global Myomectomy Market is Anticipated to Witness High Growth

Myomectomy is a surgical procedure that involves removing uterine fibroids but keeping the uterus intact. Uterine fibroids are non-cancerous tumors that grow in or on the muscular wall of the uterus and can cause painful or heavy periods, pressure symptoms, fertility problems and other complications. The need for minimally invasive procedures to treat uterine fibroids is increasing as they help in faster recovery and lesser complications compared to open surgeries. Myomectomy allows women to preserve their uterus and fertility.

Key Takeaways

Key players operating in the Global Myomectomy market are Medtronic, Stryker Corporation, CONMED Corporation, CooperSurgical Inc., Ethicon, Inc., Hologic, Inc., Minerva Surgical, Inc., INSIGHTEC, Karl Storz GmbH, Intuitive Surgical, and B. Braun Melsungen AG. These players are focusing on developing advanced surgical tools and techniques such as laparoscopic Myomectomy Market Demand and hysteroscopic myomectomy to reduce surgical risks and perform uterus-preserving procedures.

The rising awareness about uterus preservation techniques for treating fibroids is creating growth opportunities for minimally invasive procedures like laparoscopic myomectomy and robotic myomectomy. Furthermore, the growing fertility tourism and medical tourism industries in Asia Pacific and Latin American countries are encouraging women from developed markets to undergo low-cost myomectomy in these regions.

Major players are expanding their geographical presence through strategic collaboration with local healthcare providers. For instance, Hologic acquired SuperSonic Imagine, a French company offering ultrasound technologies, to expand its global footprint. Similarly, Intuitive Surgical augmented its international presence by establishing direct sales and service offices across various countries.

Market Drivers
Increasing incidence of uterine fibroids owing to changing lifestyle habits and rising obesity levels is a major market driver. According to estimates, around 70-80% women are likely to develop fibroids by the time they reach menopause. Furthermore, growing awareness about fertility preservation and the effectiveness of myomectomy in relieving fibroid-related symptoms while keeping the uterus intact is propelling the market growth.

Market Restraints
However, the high cost of minimally invasive myomectomy procedures and limited insurance coverage for such surgeries in some countries could hamper the market growth. Additionally, the risks of surgical complications like hemorrhage and injury to adjacent organs during a myomectomy procedure also act as restraining factors.

Segment Analysis

The Global Myomectomy market is dominated by the abdominal myomectomy sub segment owing to various advantages like better visualization and access of uterus, minimal blood loss, low risk of intraoperative and postoperative complications. Abdominal myomectomy allows treating larger uterine fibroids completely and extracting them out of the uterus safely which may not be possible through other minimally invasive procedures.

The dominant sub segment is followed by hysteroscopic myomectomy. Hysteroscopic myomectomy is carried out using specialized instruments introduced through the vagina and cervix to remove submucosal fibroids. It is gaining popularity due to benefits like reduced postoperative pain, shorter hospital stay, and faster recovery time compared to abdominal myomectomy. However, hysteroscopic approach has certain limitations in terms of size and number of fibroids that can be removed.

Global Analysis

Regionally, North America dominates the global myomectomy market and is expected to continue its dominance during the forecast period. High adoption of advanced gynecological procedures, developed healthcare infrastructure, and availability of skilled professionals are some factors driving the market in the region.

Europe holds the second largest market share. Increasing awareness about uterine fibroid treatment options and favorable reimbursement policies are propelling the European myomectomy market. Asia Pacific is identified as the fastest growing market for myomectomy. Factors such as rising obesity rates, growing medical tourism, and improving healthcare facilities are boosting the APAC regional market.

Get more insights on Myomectomy Market